Starlight Cardiovascular Raises $9.48M in Series A Financing
- Starlight Cardiovascular, a San Diego, CA-based preclinical stage medical technology company, raised $9.48M in Series A funding
- The round, which included conversion of previously-issued notes, was led by Bird B
- The company intends to use the funds to progress development of its portfolio of pediatric interventional cardiology devices
- StarlightCardiovascular is a preclinical stage medical technology company developing a portfolio of devices to address pediatric Congenital Heart Disease
- Its first product, a Ductus Arteriosus Stent, replaces a life-saving open chest surgery with a microcatheter-based procedure performed through a small incision in the skin
